DNA pol α inhibitors are chemical compounds designed to specifically target and inhibit the activity of DNA polymerase alpha (DNA pol α), an essential enzyme in the initiation of DNA replication. DNA pol α plays a critical role during the early stages of DNA synthesis, as it forms part of the primase complex that lays down short RNA-DNA primers required for the initiation of leading and lagging strand synthesis. This enzyme catalyzes the addition of nucleotides to the primer, beginning the process of DNA elongation. By inhibiting DNA pol α, these compounds interfere with the replication machinery, halting the progression of DNA synthesis at its earliest stages.
Structurally, DNA pol α inhibitors are typically small molecules that bind to the active site of the enzyme, preventing it from catalyzing the addition of nucleotides to the growing DNA strand. These inhibitors may act by competing with the enzyme's natural substrates (nucleotides) or by altering the enzyme's structure in a way that disrupts its catalytic activity. Inhibiting DNA pol α allows researchers to study the role of this enzyme in the replication fork, helping to dissect the mechanisms of DNA replication and repair. By blocking DNA pol α activity, researchers can also explore how the inhibition of primer synthesis affects the overall stability of the replication machinery. The use of DNA pol α inhibitors is valuable in understanding the specific contributions of this polymerase to genomic stability and the precise coordination required for accurate DNA replication.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Aphidicolin is a tetracyclic diterpene antibiotic that inhibits DNA Pol α and other DNA polymerases, affecting DNA replication. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, reducing deoxyribonucleotide pools and indirectly affecting DNA Pol α activity. | ||||||
1-β-D-Arabinofuranosylcytosine | 147-94-4 | sc-201628 sc-201628A sc-201628B sc-201628C sc-201628D | 1 g 5 g 25 g 100 g 250 g | $150.00 $263.00 $518.00 $731.00 $1461.00 | 1 | |
1-β-D-Arabinofuranosylcytosine, a cytosine nucleoside analog, can be incorporated into DNA, potentially hindering DNA Pol α function. | ||||||
Fludarabine | 21679-14-1 | sc-204755 sc-204755A | 5 mg 25 mg | $58.00 $204.00 | 15 | |
Fludarabine, a purine analog, inhibits DNA synthesis and may indirectly affect DNA Pol α activity. | ||||||
2-Chloro-2′-deoxyadenosine | 4291-63-8 | sc-202399 | 10 mg | $144.00 | 1 | |
Cladribine, another purine nucleoside analog, is incorporated into DNA, possibly influencing DNA Pol α activity. | ||||||
6-Thioguanine | 154-42-7 | sc-205587 sc-205587A | 250 mg 500 mg | $42.00 $54.00 | 3 | |
Thioguanine, a guanine analog, gets incorporated into DNA and RNA, potentially affecting DNA Pol α. | ||||||
3′-Azido-3′-deoxythymidine | 30516-87-1 | sc-203319 | 10 mg | $61.00 | 2 | |
AZT can be incorporated into DNA, potentially hindering DNA Pol α. | ||||||
Clofarabine | 123318-82-1 | sc-278864 sc-278864A | 10 mg 50 mg | $185.00 $781.00 | ||
Clofarabine is a nucleoside analog that inhibits ribonucleotide reductase and DNA synthesis, affecting DNA Pol α indirectly. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate inhibits dihydrofolate reductase, impacting nucleotide synthesis and indirectly affecting DNA Pol α. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-FU is metabolized to inhibit thymidylate synthase and can be incorporated into RNA/DNA, potentially influencing DNA Pol α. | ||||||